These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2905326)

  • 21. Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.
    Buyken AE; von Eckardstein A; Schulte H; Cullen P; Assmann G
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):230-6. PubMed ID: 17446801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperlipidemia: forestalling complications in older diabetics.
    Chait A
    Geriatrics; 1985 Apr; 40(4):71-3, 76-8. PubMed ID: 3884443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid disorders in type 1 and type 2 diabetes.
    Goldberg RB; Capuzzi D
    Clin Lab Med; 2001 Mar; 21(1):147-72, vii. PubMed ID: 11321932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Framingham risk equations underestimate coronary heart disease risk in diabetes.
    Stevens RJ; Coleman RL; Holman RR
    Diabet Med; 2005 Feb; 22(2):228. PubMed ID: 15660747
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prevention of coronary disease in clinical practice. Guidelines of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
    Pyorala K; De Backer G; Graham I; Poole-wilson P; Wood D
    G Ital Cardiol; 1996 Feb; 26(2):127-68. PubMed ID: 8666173
    [No Abstract]   [Full Text] [Related]  

  • 26. [Coronary risk assessment in subjects with type 2 diabetes mellitus. General population-based scores or specific scores?].
    Hernáez R; Choque L; Giménez M; Costa A; Márquez JI; Conget I
    Rev Esp Cardiol; 2004 Jun; 57(6):577-80. PubMed ID: 15225505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes mellitus: biological determinants of atherosclerosis and restenosis.
    Marso SP; Mak KH; Topol EJ
    Semin Interv Cardiol; 1999 Sep; 4(3):129-43. PubMed ID: 10545619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic dyslipidemia.
    Chahil TJ; Ginsberg HN
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):491-510, vii-viii. PubMed ID: 16959582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperinsulinaemia as a possible risk factor of macrovascular disease in diabetes mellitus. An overview.
    Janka HU; Standl E
    Diabete Metab; 1987 Jul; 13(3 Pt 2):279-83. PubMed ID: 3308556
    [No Abstract]   [Full Text] [Related]  

  • 30. [Major nutrition-related risk factors of ischemic heart disease: dyslipoproteinemia, obesity, hypertension, glucose intolerance].
    Pados G
    Orv Hetil; 1999 Jul; 140(28):1563-72. PubMed ID: 10443132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evidence for lipid lowering: type 2 diabetes and coronary heart disease risk.
    Townsend D; Davis R
    Prof Nurse; 2004 Jun; 19(10):38-40. PubMed ID: 15233071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statin therapy in the primary and secondary prevention of coronary artery disease in patients with type 2 diabetes. A scientific review.
    Paulo S; Fernandes S; Vizinho R; Carneiro AV
    Rev Port Cardiol; 2004 Nov; 23(11):1461-82. PubMed ID: 15693698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients.
    Tenenbaum A; Motro M; Fisman EZ; Adler Y; Shemesh J; Tanne D; Leor J; Boyko V; Schwammenthal E; Behar S
    Eur Heart J; 2005 Oct; 26(19):2032-8. PubMed ID: 15872029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in the understanding of diabetic vascular disease.
    Fujii S
    J Cardiovasc Risk; 1997 Apr; 4(2):67-9. PubMed ID: 9304486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperlipidaemia and cardiovascular disease.
    Hanna FW
    Curr Opin Lipidol; 1998 Feb; 9(1):69-71. PubMed ID: 9502339
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiovascular risk and prevention in diabetes mellitus.
    Roberts AW
    Clin Med (Lond); 2010 Oct; 10(5):495-9. PubMed ID: 21117387
    [No Abstract]   [Full Text] [Related]  

  • 37. Lipid lowering drugs in diabetes: absolute risk reduction is what counts.
    Lewis LS
    BMJ; 2006 May; 332(7552):1272. PubMed ID: 16735344
    [No Abstract]   [Full Text] [Related]  

  • 38. Hyperglycaemia and coronary heart disease: the meta picture.
    Mazzone T
    Lancet; 2009 May; 373(9677):1737-8. PubMed ID: 19465212
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperlipidemia in diabetes mellitus.
    Dunn FL
    Diabetes Metab Rev; 1990 Feb; 6(1):47-61. PubMed ID: 2192855
    [No Abstract]   [Full Text] [Related]  

  • 40. CHD and diabetes--target dyslipidaemia, reduce the risk.
    Betteridge DJ; Tuomilehto J
    Diabetes Res Clin Pract; 2003 Jul; 61 Suppl 1():S1-2. PubMed ID: 12880688
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.